Thyroid Medication Recall Elevated to Highest Warning Level: FDA
NEED TO KNOW The FDA has elevated the recall of a thyroid medication to Class I, due to…
Study identifies key risk factors driving MASLD across populations
Background and aims Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 32% of the US adult population. The…
This young woman healed from hypothyroidism using functional medicine
For many people living with chronic illness, medication is only part of the solution. Increasingly, doctors are highlighting the…
How genomic screening in newborns found 16 hidden disorders standard tests overlooked
By uncovering life-altering genetic conditions before symptoms appear, genomic screening could redefine newborn care if health systems can…